Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...
Embarking on a long road trip with your pet can be an exciting adventure, but it requires careful planning to ensure their ...